THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE

Show other versions (1)

Aim. To estimate an effect of metabolic corrector mildronate on cardiac hemodynamics and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF)Material and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included into the study...

Full description

Bibliographic Details
Main Authors: I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
metabolic corrector
ischemic heart disease
heart failure
cardiac hemodynamics
Online Access:https://www.rpcardio.online/jour/article/view/497

Internet

https://www.rpcardio.online/jour/article/view/497

Similar Items